Tenvir EM Tablets | Emtricitabine + Tenofovir Disoproxil Fumarate

Tenvir EM Tablets is a widely prescribed antiretroviral medicine used for the treatment and prevention of Human Immunodeficiency Virus (HIV-1) infection. It is a fixed-dose combination of Emtricitabine 200 mg and Tenofovir Disoproxil Fumarate 300 mg, two potent nucleoside reverse transcriptase inhibitors (NRTIs).

Manufactured by Cipla Ltd, Tenvir EM Tablets are globally recognized for their effectiveness in both HIV treatment and Pre-Exposure Prophylaxis (PrEP). When taken consistently as prescribed, it helps reduce viral load, improve immune response, and lower the risk of HIV transmission..

Active Ingredients & Composition

Each film-coated tablet of Tenvir EM Tablets contains:

• Emtricitabine – 200 mg

• Tenofovir Disoproxil Fumarate – 300 mg

These active ingredients work synergistically to block HIV replication at an early stage.

How Tenvir EM Tablets Work

Emtricitabine

Emtricitabine inhibits the reverse transcriptase enzyme, preventing HIV from converting its RNA into DNA, which is essential for viral replication.

Tenofovir Disoproxil Fumarate

Tenofovir Disoproxil Fumarate is converted into tenofovir inside the body, which also blocks reverse transcriptase, effectively stopping HIV from multiplying.

Together, these agents significantly reduce HIV viral load when used correctly.

Uses of Tenvir EM Tablets

Tenvir EM Tablets are used for:

• Treatment of HIV-1 infection

• Pre-Exposure Prophylaxis (PrEP) to prevent HIV infection

• Combination therapy in antiretroviral regimens

• Reducing HIV transmission risk

• Improving CD4 cell count

• Long-term HIV management

⚠️ Tenvir EM Tablets do not cure HIV but help control the infection effectively.

Benefits of Tenvir EM Tablets

• Proven effectiveness in HIV treatment and prevention

• WHO-recommended components

• Suitable for once-daily dosing

• Widely used in global HIV programs

• Trusted manufacturer: Cipla Ltd

• Cost-effective generic formulation

How to Take Tenvir EM Tablets

• Take one tablet once daily

• Can be taken with or without food

• Swallow whole with water

• Take at the same time every day for maximum benefit

Dosage & Administration

Recommended Dosage

• Adults: One tablet once daily, as prescribed

Missed Dose

• Take as soon as remembered

• Skip if close to the next dose

• Do not double the dose

Overdose

Seek immediate medical attention in case of overdose.

Directions for Use

• Use strictly under medical supervision

• Do not stop treatment without consulting your doctor

• Regular monitoring of kidney function is advised

• Maintain consistent daily intake

Safety Information & Warnings

Prescription Only Medicine (Rx)

Before using Tenvir EM Tablets, inform your doctor if you have:

• Kidney disease

• Liver problems (including hepatitis B)

• Bone disorders

• Pregnancy or breastfeeding concerns

Possible Side Effects

Common Side Effects

• Nausea

• Headache

• Diarrhea

• Fatigue

• Dizziness

Serious Side Effects (Rare)

• Kidney impairment

• Bone mineral density loss

• Lactic acidosis

Seek medical advice if serious symptoms occur.

Drug Interactions

Tenvir EM Tablets may interact with:

• Other antiretroviral medicines

• Nephrotoxic drugs

• Certain antivirals and antibiotics

Always inform your healthcare provider about all medications you are taking.

Storage Instructions

• Store below 30°C

• Protect from moisture and sunlight

• Keep out of reach of children

• Do not use after expiry date

Different Brand Names Available in the Market

The same active ingredients are available under various brand names, including:

• Tenvir EM Tablets

• Truvada®

• Other approved generic versions

Availability may vary by country.

Frequently Asked Questions (FAQs)

Is Tenvir EM Tablets used for PrEP?

Yes, it is commonly prescribed for HIV prevention (PrEP).

Can Tenvir EM Tablets cure HIV?

No, it controls the infection but does not cure it.

Is Tenvir EM safe for long-term use?

Yes, when taken under medical supervision.

Why Choose Tenvir EM Tablets?

• Trusted global manufacturer (Cipla Ltd)

• Clinically proven combination

• High patient adherence

• WHO-recommended formulation

• Suitable for HIV treatment and prevention

WHO – HIV Treatment & PrEP Guidelines

U.S. FDA – Truvada (Emtricitabine + Tenofovir DF) Label

NIH – HIV Clinical Guidelines

CDC – HIV Treatment & Prevention (PrEP)

Manufacturer Website – Cipla Ltd

Additional Official Regulatory Resource – DOH / HTAC PDF